Related Experiment Videos
Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain
Pia März1, Jörg Stetefeld, Kerstin Bendfeldt
1Institute of Physiology, Pestalozzistr. 20, University of Basel, CH-4056 Basel, Switzerland.
Abstract:
Modification by O-GlcNAc involves a growing number of eucaryotic nuclear and cytosolic proteins. Glycosylation of intracellular proteins is a dynamic process that in several cases competes with and acts as a reciprocal modification system to phosphorylation. O-Linked beta-N-acetylglucosamine transferase (OGT) levels are highest in the brain, and neurodegenerative disorders such as Alzheimer disease have been shown to involve abnormally phosphorylated key proteins, probably as a result of hypoglycosylation. Here, we show that the neurodegenerative disease protein ataxin-10 (Atx-10) is associated with cytoplasmic OGT p110 in the brain. In PC12 cells and pancreas, this association is competed by the shorter OGT p78 splice form, which is down-regulated in brain. Overexpression of Atx-10 in PC12 cells resulted in the reconstitution of the Atx-10-OGT p110 complex and enhanced intracellular glycosylation activity. Moreover, in an in vitro enzyme assay using PC12 cell extracts, Atx-10 increased OGT activity 2-fold. These data indicate that Atx-10 might be essential for the maintenance of a critical intracellular glycosylation level and homeostasis in the brain.
Insights
Ataxin-10 (Atx-10) interacts with O-linked beta-N-acetylglucosamine transferase (OGT) in the brain, enhancing intracellular glycosylation. This suggests Atx-10 is crucial for maintaining brain glycosylation homeostasis.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- O-GlcNAc modification impacts numerous eukaryotic nuclear and cytosolic proteins.
- Intracellular protein glycosylation dynamically competes with and reciprocally modifies phosphorylation.
- Elevated O-linked beta-N-acetylglucosamine transferase (OGT) levels are found in the brain, where altered phosphorylation is linked to neurodegenerative diseases like Alzheimer's, potentially due to reduced glycosylation.
Purpose of the Study:
- To investigate the role of the neurodegenerative disease protein ataxin-10 (Atx-10) in intracellular glycosylation.
- To determine the interaction between Atx-10 and OGT in neuronal cells.
- To explore the functional consequences of Atx-10 and OGT interaction on glycosylation activity.
Main Methods:
- Co-immunoprecipitation to detect Atx-10 and OGT complex formation in brain tissue and cell lines.
- Analysis of OGT splice variants (p110 and p78) in different tissues.
- Overexpression studies in PC12 cells to assess the impact on glycosylation activity.
- In vitro enzyme assays to quantify OGT activity in the presence of Atx-10.
Main Results:
- Ataxin-10 (Atx-10) was found to associate with the cytoplasmic OGT p110 splice form in the brain.
- This Atx-10-OGT p110 interaction was competed by the shorter OGT p78 splice form, which is less abundant in the brain.
- Overexpression of Atx-10 in PC12 cells reconstituted the Atx-10-OGT p110 complex and increased intracellular glycosylation.
- In vitro assays demonstrated that Atx-10 enhances OGT activity twofold.
Conclusions:
- Ataxin-10 (Atx-10) forms a complex with OGT p110 in the brain, suggesting a role in regulating intracellular glycosylation.
- The interaction and activity of OGT may be modulated by Atx-10, impacting glycosylation levels.
- Atx-10 is potentially essential for maintaining critical intracellular glycosylation levels and homeostasis within the brain.
Related Concept Videos
Botulism
Tetanus
ATP Synthase: Mechanism
Hepatic Encephalopathy
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...